[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-307143-105":53,"doc-detail-307143-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","institutional-review-board-deception-or-incomplete-disclosure","Institutional Review Board Deception or Incomplete Disclosure","","Institutional Review Board policy for the University of Georgia addresses when deception and incomplete disclosure may be used in human subjects research. The policy explains ethical concerns related to informed consent, defines deception and incomplete disclosure, and sets requirements for justification in IRB submissions. It specifies participant protections, limits on misleading about significant or harm-related aspects, and requirements for debriefing and consent waivers or alterations. Researchers must detail procedures, risks, and mitigation steps, including debriefing form or script submission, and describe eligibility for exempt determination when subject authorization is obtained.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":41,"@type":70,"position":76},"https://docshare.wps.com/template/letters/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/institutional-review-board-deception-or-incomplete-disclosure/307143/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/institutional-review-board-deception-or-incomplete-disclosure/307143.png","ImageObject",442,249,{"name":88,"@type":89},"Fans","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-18","2026-09-19",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",6,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"Why does the IRB allow deception or incomplete disclosure in some human subjects research?","Question",{"text":109,"@type":110},"The University of Georgia IRB recognizes that deception and incomplete disclosure may be necessary, but their use creates ethical concerns because they interfere with participants’ ability to give informed consent. The policy therefore sets responsibilities and special considerations for IRB review.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"How does the policy define deception and incomplete disclosure?",{"text":114,"@type":110},"Deception is the intentional misleading of participants through false or misleading information about aspects of the research. Incomplete disclosure occurs when investigators withhold information about some aspects of the research, typically the real purpose or nature of the study.",{"name":116,"@type":107,"acceptedAnswer":117},"What requirements apply to consent and debriefing when deception or incomplete disclosure is used?",{"text":118,"@type":110},"Deception or incomplete disclosure must be justified in the IRB submission and cannot be used to entice participation or mislead about significant aspects affecting willingness or anticipated physical/emotional harm. For non-exempt studies, deception/incomplete disclosure must be explained to participants through debriefing as early as feasible unless a waiver or delayed debriefing is justified; for exempt studies, debriefing is not required, and a waiver or alteration of informed consent elements must be approved when a truly informed consent cannot be given.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},307143,1790717357,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":40,"category_name":41,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":47,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":73},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","UNIVERSITY OF GEORGIA  \nInstitutional Review Board Deception or Incomplete Disclosure  \n\n| Number: | Date: | Author: | Approved By: | Page(s): |\n| --- | --- | --- | --- | --- |\n| UGAHRP-097-1 | 09/ 16/2016 | HSO | IRB | Page 1 of 5 |\n\n1. PURPOSE  \n1.1. The University of Georgia Institutional Review Board ( UGA IRB) recognizes that the use of deception and incomplete disclosure may be necessary in some human subjects research. While these are accepted research techniques, their use raise ethical concerns because they primarily interfere with the ability of the potential participant to give informed consent. This policy describes the responsibilities of the investigator and special considerations when the IRB reviews research involving deception or incomplete disclosure.  \n2. DEFINITIONS  \n2.1. Deception: the intentional misleading of research participants by providing false or misleading information about some aspects of the research. False or misleading information might relate to the purpose of the research, the role of the researcher or other participants, the true nature of the procedures to be followed, or other parts of the study.  \n2.2. Incomplete Disclosure: occurs when investigators withhold information to participants about some aspects of the research (typically, about the real purpose or nature of the study) .  \n3. POLICY  \n3.1. The use of deception/incomplete disclosure must be justified in the IRB submission to show that the research cannot be performed in its absence.  \n3.2. The research participants cannot be deceived about significant aspects of the research that would affect their willingness to participate.  \n3.3. These techniques cannot be used to entice or lure a human subject to participate.  \n3.4. The research participants cannot be deceived or not be fully informed about aspects of the research that are anticipated to cause physical or emotional harm, or which pose greater than minimal risk to the participants.  \n3.5. The benefits of the research will sufficiently outweigh any risks that deception or incomplete disclosure may create.  \n3.6. For non-exempt studies, deception/incomplete disclosure will be explained to participants (through debriefing) as early as feasible unless a waiver or delayed debriefing is justified.  \n3.7. For exempt studies regardless of funding and funding source, debriefing will not be required.  \n3.8. A truly “informed consent” cannot be given if there is deception/incomplete disclosure so a waiver of or alteration of some informed consent elements must be approved by the IRB.  \n3.9. Human research using deception or incomplete disclosure regarding the nature or purpose of the research is eligible for exempt determination if it meets the exempt criteria and only if the subject authorizes the deception or incomplete disclosure. Authorized deception or incomplete disclosure would be the prospective agreement by the subject to participate in  \nUNIVERSITY OF GEORGIA  \nInstitutional Review Board Deception or Incomplete Disclosure  \n\n| Number: | Date: | Author: | Approved By: | Page(s): |\n| --- | --- | --- | --- | --- |\n| UGAHRP-097-0 | 09/ 16/2016 | HSO | IRB | Page 2 of 5 |\n\nresearch where the subject (or subject’s legally authorized representative) is informed that he or she will be unaware of (or misled) regarding the nature or purpose of the research. See Policy and Procedure: Exempt Review.  \n4. PROCEDURES: Researchers  \n4.1. IRB Submission  \n4.1.1. Describe in detail the deception/incomplete disclosure, and provide a scientific justification for why this is necessary to achieve the goals of the study (i.e., how it relates to the study aims and study design) . Including if alternative methods not involving use of deception/incomplete disclosure were considered and why these methods are not applicable will be helpful.  \n4.1.2. Explain the procedure to debrief participants (i.e., when and how participants will be debriefed) . A debriefing form or script that will be given or read ","cbCaituRcUJjpbSg","https://ap.wps.com/l/cbCaituRcUJjpbSg","pdf",172814,"English","# PURPOSE\n# DEFINITIONS\n# POLICY\n# PROCEDURES: Researchers\n## IRB Submission\n## Informed Consent Requirements","[{\"question\":\"Why does the IRB allow deception or incomplete disclosure in some human subjects research?\",\"answer\":\"The University of Georgia IRB recognizes that deception and incomplete disclosure may be necessary, but their use creates ethical concerns because they interfere with participants’ ability to give informed consent. The policy therefore sets responsibilities and special considerations for IRB review.\"},{\"question\":\"How does the policy define deception and incomplete disclosure?\",\"answer\":\"Deception is the intentional misleading of participants through false or misleading information about aspects of the research. Incomplete disclosure occurs when investigators withhold information about some aspects of the research, typically the real purpose or nature of the study.\"},{\"question\":\"What requirements apply to consent and debriefing when deception or incomplete disclosure is used?\",\"answer\":\"Deception or incomplete disclosure must be justified in the IRB submission and cannot be used to entice participation or mislead about significant aspects affecting willingness or anticipated physical/emotional harm. For non-exempt studies, deception/incomplete disclosure must be explained to participants through debriefing as early as feasible unless a waiver or delayed debriefing is justified; for exempt studies, debriefing is not required, and a waiver or alteration of informed consent elements must be approved when a truly informed consent cannot be given.\"}]","Institutional Review Board Deception or Incomplete Disclosure | PDF",1789844822]